[HTML][HTML] Diurnal effects of polypharmacy with high drug burden index on physical activities over 23 h differ with age and sex

T Tran, J Mach, G Gemikonakli, H Wu, H Allore… - Scientific reports, 2022 - nature.com
Aging, polypharmacy (concurrent use of≥ 5 medications), and functional impairment are
global healthcare challenges. However, knowledge of the age/sex-specific effects of …

Polypharmacy results in functional impairment in mice: novel insights into age and sex interactions

H Wu, J Mach, G Gemikonakli, T Tran… - The Journals of …, 2021 - academic.oup.com
Males and females may respond differently to medications, yet knowledge about sexual
dimorphisms in the effects of polypharmacy remains limited, particularly in aging. This study …

Chronic polypharmacy with increasing drug burden index exacerbates frailty and impairs physical function, with effects attenuated by deprescribing, in aged mice

J Mach, G Gemikonakli, C Logan… - The Journals of …, 2021 - academic.oup.com
Polypharmacy (use of≥ 5 medications) and increasing Drug Burden Index (DBI) score
(measure of person's total exposure to anticholinergic/sedative medications) are associated …

[HTML][HTML] Long-term exposure to polypharmacy impairs cognitive functions in young adult female mice

E Francesca, J Kristina, LL María, H Sarah… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
The potential harmful effects of polypharmacy (concurrent use of 5 or more drugs) are
difficult to investigate in an experimental design in humans. Moreover, there is a lack of …

The effect of polypharmacy on prefrontal cortex activation during single and dual task walking in community dwelling older adults

CJ George, J Verghese, M Izzetoglu, C Wang… - Pharmacological …, 2019 - Elsevier
Introduction Polypharmacy, defined as the use of 5 or more medications is associated with
multiple adverse outcomes in older adults, including falls and slow gait velocity. However …

[HTML][HTML] Chronic polypharmacy impairs explorative behavior and reduces synaptic functions in young adult mice

F Eroli, K Johnell, ML Leal, C Adamo, S Hilmer… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
A major challenge in the health care system is the lack of knowledge about the possible
harmful effects of multiple drug treatments in old age. The present study aims to characterize …

[HTML][HTML] Polypharmacy, physical activity, and sedentary time in older adults: A scoping review

IKC de Souza, FJ Rosa-Souza… - Experimental …, 2023 - Elsevier
Objective To map out the studies that have investigated the associations of polypharmacy
and/or potentially inappropriate medication (PIM) use with physical activity and sedentary …

Adverse geriatric outcomes secondary to polypharmacy in a mouse model: the influence of aging

A Huizer-Pajkos, AE Kane, SE Howlett… - … Series A: Biomedical …, 2016 - academic.oup.com
We aimed to develop a mouse model of polypharmacy, primarily to establish whether short-
term exposure to polypharmacy causes adverse geriatric outcomes. We also investigated …

[HTML][HTML] Psychotropic polypharmacy in adults 55 years or older: a risk for impaired global cognition, executive function, and mobility

G Loggia, E Attoh-Mensah, K Pothier… - Frontiers in …, 2020 - frontiersin.org
Objectives With their broad spectrum of action, psychotropic drugs are among the most
common medications prescribed to the elderly. Consequently, the number of older adults …

[HTML][HTML] Using wrist-worn accelerometers to identify the impact of medicines with anticholinergic or sedative properties on sedentary time: a 12-month prospective …

R Lim, D Dumuid, G Parfitt, T Stanford, D Post, R Bilton… - Maturitas, 2023 - Elsevier
Introduction Studies have shown that use of medicines with sedative or anticholinergic
properties is associated with a decline in physical function; however, the effects have not …